Characterization of the Mouse Beta Defensin 1, Defb1, Mutant Mouse Model

ABSTRACT Beta defensins are small cationic antimicrobial peptides present in the respiratory system which have been proposed to be dysfunctional in the environment of the cystic fibrosis lung. Defb1, a murine homologue to the human beta defensins, has also been found to be expressed in the respiratory system and, in order to examine the function of beta defensins in vivo, gene targeting was used to generate Defb1-deficient (Defb1tm1Hgu/Defb1tm1Hgu [Defb1−/−]) mice. The Defb1 synthetic peptide was shown to have a salt-sensitive antimicrobial activity that was stronger against Staphylococcus aureus than against Escherichia coli or Pseudomonas aeruginosa. Defb1−/− mice were found, however, to be effective in the clearance of the cystic fibrosis relevant pathogen S. aureus from the airways after nebulization. Although no overt deleterious phenotype was evident in the Defb1−/− mice, the number of mutant mice found to harbor bacteria of the Staphylococcus species in the bladder was significantly higher (P = 0.008) than that of controls, suggesting a role for these peptides in resistance to urinary tract infection.

[1]  Jesse D. Walters,et al.  Discovery of five conserved β-defensin gene clusters using a computational search strategy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Y. Ouchi,et al.  A Novel Mouse β-Defensin, mBD-6, Predominantly Expressed in Skeletal Muscle* , 2001, The Journal of Biological Chemistry.

[3]  O. Chertov,et al.  The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity , 2001, Cellular and Molecular Life Sciences CMLS.

[4]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[5]  G. K. Johnson,et al.  Discovery of new human β-defensins using a genomics-based approach , 2001 .

[6]  P. McCray,et al.  A Novel Murine β-Defensin Expressed in Tongue, Esophagus, and Trachea* , 2000, The Journal of Biological Chemistry.

[7]  S. Randell,et al.  CD14-dependent Lipopolysaccharide-induced β-Defensin-2 Expression in Human Tracheobronchial Epithelium* , 2000, The Journal of Biological Chemistry.

[8]  Jun Yuan,et al.  A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. , 1999, Science.

[9]  T. Ganz,et al.  Innate Antimicrobial Activity of Nasal Secretions , 1999, Infection and Immunity.

[10]  S. Wattler,et al.  Mouse β-Defensin 3 Is an Inducible Antimicrobial Peptide Expressed in the Epithelia of Multiple Organs , 1999, Infection and Immunity.

[11]  J. Schröder,et al.  Human beta-defensin-2. , 1999, The international journal of biochemistry & cell biology.

[12]  D. Davidson,et al.  A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide , 1999, FEBS letters.

[13]  H. Heng,et al.  Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. , 1998, Gene.

[14]  V. Bafna,et al.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.

[15]  D. Davidson,et al.  Mouse beta defensin-1 is a functional homolog of human beta defensin-1 , 1998, Mammalian Genome.

[16]  Christina H. Park,et al.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. , 1998, The Journal of clinical investigation.

[17]  James M. Wilson,et al.  Mouse β-Defensin 1 Is a Salt-Sensitive Antimicrobial Peptide Present in Epithelia of the Lung and Urogenital Tract , 1998, Infection and Immunity.

[18]  C. Kozak,et al.  The mouse genome encodes a single homolog of the antimicrobial peptide human β‐defensin 1 , 1997, FEBS letters.

[19]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[20]  P. McCray,et al.  Human airway epithelia express a beta-defensin. , 1997, American journal of respiratory cell and molecular biology.

[21]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[22]  E. Greenberg,et al.  Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid , 1996, Cell.

[23]  D. Porteous,et al.  Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens , 1995, Nature Genetics.

[24]  M. Zasloff,et al.  Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. K. Johnson,et al.  Discovery of new human beta-defensins using a genomics-based approach. , 2001, Gene.

[26]  J. R. García,et al.  Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  R. Hancock,et al.  Cationic antimicrobial peptides and their multifunctional role in the immune system. , 2000, Critical reviews in immunology.

[28]  P. McCray,et al.  A novel murine beta -defensin expressed in tongue, esophagus, and trachea. , 2000, The Journal of biological chemistry.

[29]  A. Furst,et al.  Intratracheal instillation method for mouse lungs. , 1973, Oncology.

[30]  James M. Wilson.  The genesis of cystic fibrosis lung disease , 2022 .